Boehringer and Walgreens partner to enhance clinical trial accessibility

Boehringer Ingelheim and US-based pharmacy store chain Walgreens have entered into a strategic partnership to optimise clinical trial recruitment and improve accessibility, inclusivity and equity.

This deal expects to use select Walgreens pharmacies as clinical trial sites for individuals with obesity, overweight, and type 2 diabetes, focusing on Phase III clinical research.